Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PPH vs SCHLX overlap: 50% of top holdings shared

Bottom line

How much do PPH and SCHLX overlap?

50% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 75.8% of PPH's assets and 44.2% of SCHLX's. They share a meaningful core but differ in the rest of the portfolio.

SCHLX holds far more positions (65 vs 26), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

PPHSCHLX
Weight overlap (top 25)50%
Shared holdings11
Weight in shared holdings75.8%44.2%
Total positions2665
Expense ratio0.36%1.06%
Holdings as ofJun 30, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Holdings PPH and SCHLX have in common

Holding% of PPH% of SCHLXOverlap
Eli Lilly & Co20.23%13.85%13.85%
Novartis AG10.63%2.90%2.90%
Merck & Co Inc9.85%4.85%4.85%
Novo Nordisk A/S5.37%1.73%1.73%
AbbVie Inc4.57%4.90%4.57%
Pfizer Inc4.51%1.17%1.17%
Bristol-Myers Squibb Co4.47%1.50%1.50%
Johnson & Johnson4.35%6.19%4.35%
AstraZeneca PLC4.33%3.80%3.80%
McKesson Corp4.12%2.05%2.05%
Cencora Inc3.36%1.26%1.26%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PPH

  1. Gsk Plc — 4.42%
  2. Sanofi SA — 4.00%
  3. Haleon PLC — 3.09%
  4. Teva Pharmaceutical Industries Ltd — 3.06%
  5. Takeda Pharmaceutical Co Ltd — 2.87%
  6. Zoetis Inc — 2.10%
  7. Viatris Inc — 1.10%
  8. Jazz Pharmaceuticals PLC — 1.08%
  9. Axsome Therapeutics Inc — 0.77%
  10. Corcept Therapeutics Inc — 0.50%
  11. Elanco Animal Health Inc — 0.35%
  12. State Street Global Advisors — 0.28%
  13. Organon & Co — 0.23%
  14. Bausch Health Cos Inc — 0.10%

Only in SCHLX

  1. UnitedHealth Group Inc — 5.73%
  2. Thermo Fisher Scientific Inc — 3.46%
  3. Amgen Inc — 2.88%
  4. Gilead Sciences Inc — 2.78%
  5. Intuitive Surgical Inc — 2.69%
  6. Stryker Corp — 2.61%
  7. Vertex Pharmaceuticals Inc — 2.45%
  8. Abbott Laboratories — 2.39%
  9. Danaher Corp — 2.13%
  10. Boston Scientific Corp — 2.10%
  11. Medtronic PLC — 1.54%
  12. Regeneron Pharmaceuticals Inc — 1.43%
  13. Cardinal Health Inc — 1.34%
  14. Roche Holding AG — 1.24%

Asset mix

Asset typePPHSCHLX
Stocks99.5%99.6%
Cash & short-term funds0.3%0.5%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Country mix

CountryPPHSCHLX
US60.8%85.7%
GB11.8%3.8%
CH10.6%5.2%
DK5.4%1.7%
FR4.0%1.0%
IL3.1%—
JP2.9%—
IE1.1%1.5%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Check another pair

FAQ

How much do PPH and SCHLX overlap?
About 50% by weight. 11 securities appear in both funds' top 25 holdings; they make up 75.8% of PPH's assets and 44.2% of SCHLX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do PPH and SCHLX have in common?
The largest shared holdings are Eli Lilly & Co, Merck & Co Inc, AbbVie Inc, Johnson & Johnson, AstraZeneca PLC.
Should I own both PPH and SCHLX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, PPH or SCHLX?
SCHLX is broader, with 65 positions versus 26 for PPH. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.